Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications.
Naumann M, Carruthers A, Carruthers J, Aurora SK, Zafonte R, Abu-Shakra S, Boodhoo T, Miller-Messana MA, Demos G, James L, Beddingfield F, VanDenburgh A, Chapman MA, Brin MF.
Naumann M, et al. Among authors: demos g.
Mov Disord. 2010 Oct 15;25(13):2211-8. doi: 10.1002/mds.23254.
Mov Disord. 2010.
PMID: 20737546